Knowledge is not all you need for comfort in use of AI in healthcare.

Objectives: The adoption of artificial intelligence (AI) in healthcare is rapidly expanding, transforming areas such as diagnostics, drug discovery, and patient monitoring. Despite these advances, public perceptions of AI in healthcare, particularly in Canada, remain underexplored. This study investigates the relationship between Canadians' knowledge, comfort, and trust in AI, focusing on key sociodemographic factors like age, gender, education, and income.

Estimation and Conformity Evaluation of Multi-Class Counterfactual Explanations for Chronic Disease Prevention.

Recent advances in Artificial Intelligence (AI) in healthcare are driving research into solutions that can provide personalized guidance. For these solutions to be used as clinical decision support tools, the results provided must be interpretable and consistent with medical knowledge. To this end, this study explores the use of explainable AI to characterize the risk of developing cardiovascular disease in patients diagnosed with chronic obstructive pulmonary disease.

Exploring Prediabetes Pathways Using Explainable AI on Data from Electronic Medical Records.

This study leverages data from a Canadian database of primary care Electronic Medical Records to develop machine learning models predicting type 2 diabetes mellitus (T2D), prediabetes, or normoglycemia. These models are used as a basis for extracting counterfactual explanations and derive personalized changes in biomarkers to prevent T2D onset, particularly in the still reversible prediabetic state. The models achieve satisfactory performance.

Validation of a Design Architecture to Deliver Health Management and Behavior Change Evidence at Scale.

Forty-four percent of Canadians over the age of 20 have a non-communicable disease (NCD). Millions of Canadians are at risk of developing the complications of NCDs; millions have already experienced those complications. Fortunately, the evidence base for NCD prevention and behavior change is large and growing and digital technologies can deliver them at scale and with high fidelity.

AI Can Improve the Economics of Blindness Prevention in Canada.

Diabetic retinopathy is a leading cause of vision loss in Canada and creates significant economic and social burden on patients. Diabetic retinopathy is largely a preventable complication of diabetes mellitus. Yet, hundreds of thousands of Canadians continue to be at risk and thousands go on to develop vision loss and disability.